Novo Nordisk A/S vs Tripadvisor Inc Common Stock — how do they compare? Novo Nordisk A/S trades at $49.35 (market cap $220.53B), while Tripadvisor Inc Common Stock trades at $13.82 (market cap $1.68B). The key difference: Novo Nordisk A/S is far larger — about 131.3× Tripadvisor Inc Common Stock's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Tripadvisor Inc Common Stock pays none. Which is the better fit depends on your goals.
| NVO | TRIP | |
|---|---|---|
Market Cap | $220.53B | $1.68B |
Sector | Health | Consumer Cyclical |
52-Week High | $71.70 | $19.14 |
52-Week Low | $35.29 | $9.24 |
Enterprise Value | $239.49B | $1.80B |
Dividend Yield | 3.63% | — |
Trailing returns across standard periods
Latest headlines on both assets
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →